Menu
Back to Journals » Vascular Health and Risk Management » Volume 7
Treatment options for hypertension in high-risk patients
Authors Tsai W
Published 9 March 2011 Volume 2011:7 Pages 137—141
DOI https://doi.org/10.2147/VHRM.S11235
Review by Single anonymous peer review
Peer reviewer comments 4
Wei-Chuan Tsai
Department of Internal Medicine, National Cheng Kung University Hospital, Tainan, Taiwan
Abstract: Patients are considered to be at high risk of cardiovascular events if they have diabetes, chronic kidney disease, stroke, established coronary artery disease, or a coronary artery disease equivalent. Blood pressure-lowering therapy has been shown to reduce cardiovascular events in these patients significantly. Identification of high-risk patients by global risk evaluation is recommended for every hypertensive patient. Treatment of hypertension in high-risk patients with an angiotensin-converting enzyme inhibitor or an angiotensin receptor antagonist, with or without addition of a dihydropyridine calcium channel antagonist, is a reasonable approach based on current clinical trials.
Keywords: hypertension, high-risk, antihypertensive agent
© 2011 The Author(s). This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License.
By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.